Published November 2021 | Version v1
Journal article Metadata-only

Radiology departmental policy compliance with Swedish guidelines regarding post-contrast acute kidney injury for examinations with iodinated contrast media

Creators

  • 1. Department of Natural Science and Biomedicine, School of Health and Welfare, Jönköping University, Jönköping (Sweden)
  • 2. Department of Radiology, Höglandssjukhuset, Eksjö (Sweden)
  • 3. Department of Radiology, Motala Hospital, Motala (Sweden)
  • 4. Center for Medical Image Science and Visualization (CMIV), Linköping University, Linköping (Sweden)
  • 5. Department of Radiology in Linköping, and Department of Health, Medicine and Caring Sciences, Linköping University, Linköping (Sweden)

Description

Guidelines concerning intravenous iodinated contrast media (CM) during computed tomography (CT) examinations are important to follow to minimize the risk for post-contrast acute kidney injury (PC-AKI). The purpose of this study was to investigate the radiology departmental policy compliance with Swedish guidelines concerning PC-AKI.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.radi.2021.04.009

Additional details

Identifiers

DOI
10.1016/j.radi.2021.04.009;
PII
S1078817421000481;

Publishing Information

Journal Title
Radiography (London 1995)
Journal Volume
27
Journal Issue
4
Journal Page Range
p. 1058-1063
ISSN
1078-8174

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
53123969
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
BIOMEDICAL RADIOGRAPHY; COMPLIANCE; COMPUTERIZED TOMOGRAPHY; CONTRAST MEDIA; HEALTH HAZARDS; INJURIES; KIDNEYS; PATIENTS; RECOMMENDATIONS; SAFETY; SWEDEN
Descriptors DEC
BODY; DEVELOPED COUNTRIES; DIAGNOSTIC TECHNIQUES; DISEASES; EUROPE; HAZARDS; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; SCANDINAVIA; TOMOGRAPHY; WESTERN EUROPE

Optional Information

Copyright
Copyright (c) 2021 The College of Radiographers. Published by Elsevier Ltd.